Bruna Calsina Selected Research

Hypoxia (Hypoxemia)

12/2023	Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas.
4/2023	Genetic bases of pheochromocytoma and paraganglioma.
10/2020	Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma.
5/2019	Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruna Calsina Research Topics

Disease

22	Neoplasms (Cancer) 02/2024 - 01/2017
10	Paraganglioma (Paragangliomas) 12/2023 - 12/2018
8	Pheochromocytoma 01/2023 - 12/2018
4	Hypoxia (Hypoxemia) 12/2023 - 05/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 01/2020
2	Kidney Neoplasms (Kidney Cancer) 01/2023 - 05/2019
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2023
2	Disease Progression 11/2020 - 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 12/2023
1	Melanoma (Melanoma, Malignant) 01/2022
1	Dwarfism 11/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2020
1	Hearing Loss (Hearing Impairment) 07/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Inflammation (Inflammations) 05/2019
1	Carcinogenesis 05/2019
1	Nervous System Diseases (Neurological Disorders) 05/2019
1	Leiomyoma (Uterine Fibroids) 05/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Breast Neoplasms (Breast Cancer) 09/2017

Drug/Important Bio-Agent (IBA)

3	Phosphotransferases (Kinase)IBA 04/2023 - 09/2017
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2020
3	CatecholaminesIBA 01/2021 - 10/2020
3	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	Epinephrine (Adrenaline)FDA LinkGeneric 12/2023 - 10/2020
2	MTOR InhibitorsIBA 01/2023 - 01/2020
2	Estrogen ReceptorsIBA 01/2022 - 09/2017
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021 - 05/2019
2	Messenger RNA (mRNA)IBA 01/2020 - 05/2019
2	Hormones (Hormone)IBA 01/2019 - 09/2017
1	Mitogen-Activated Protein KinasesIBA 12/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	ProteomeIBA 01/2023
1	Deubiquitinating EnzymesIBA 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2021
1	Succinic Acid (Succinate)IBA 01/2021
1	tryptophyltryptophanIBA 11/2020
1	ChromatinIBA 11/2020
1	NormetanephrineIBA 10/2020
1	MetanephrineIBA 10/2020
1	3-methoxytyramine (methoxytyramine)IBA 10/2020
1	12S ribosomal RNAIBA 07/2020
1	AminoglycosidesIBA 07/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	PolyaminesIBA 01/2020
1	EnzymesIBA 05/2019
1	endothelial PAS domain-containing protein 1IBA 05/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2019
1	Tricarboxylic AcidsIBA 05/2019
1	alpha-hydroxyglutarateIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	MethyltransferasesIBA 12/2018
1	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 12/2018
1	A-Form DNA (A-DNA)IBA 12/2018
1	HeterochromatinIBA 09/2017
1	GalactosidasesIBA 09/2017
1	Adenosine Triphosphate (ATP)IBA 09/2017
1	abemaciclibIBA 09/2017
1	ParaffinIBA 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017

Therapy/Procedure

2	Immunotherapy 02/2024 - 01/2023
2	Therapeutics 02/2024 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2019